Dr Helen Murphy is a Professor of Medicine (Diabetes and Antenatal Care) at the University of East Anglia, and a practicing clinician (Norfolk & Norwich University Hospital NHS Foundation Trust). She co-led the CONCEPTT Continuous Glucose Monitoring (CGM) trial, which led to changes in clinical practice. Her studies in collaboration with Professor Roman Hovorka, demonstrate that pregnancy-specific hybrid closed-loop systems (CamAPS FX) will transform the management of T1D before, during and after pregnancy. Based on 15 years of clinical research, with pivotal studies, published in the New England Journal of Medicine, the CamAPS FX hybrid closed-loop system is licensed for use during T1D pregnancy, endorsed by the 2023 NICE technical appraisal, and nationally funded for women who are pregnant or planning pregnancy.

Helen also serves as clinical lead for the National Pregnancy in Diabetes (NPID) audit, which directly informs national healthcare policy.